RNA interference (RNAi) Market Snapshot
RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.

RNA interference (RNAi) Market is expected to see potential upside in years to come. The assessment aims are to provide a viewpoint on upcoming trends, growth drivers, opinions, and facts derived from industry executives with statistically supported and market validated data. Furthermore, details on How or Why this market may see a growth momentum during the forecast period is analyzed and correlated with dominating and emerging players strength and weakness.

The Study also encompasses COVID-19 Outbreak & Impact Analysis, how RNA interference (RNAi) Industry would develop, and what business strategies industry players are considering to overcome challenges. A holistic study of the RNA interference (RNAi) market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The analysis found the shift in market paradigms in terms of the local and global competitive edge of major players.

RNA interference (RNAi) Market Scope

RNA interference (RNAi) market is segmented on the basis of type (Chemical synthesis, In vitro transcription, In vivo expression), end-use application (Drug Discovery and Development, Therapeutics), and distribution channels, Players, and Region.

Market Data Breakdown and Growth Pattern by Type

• Chemical synthesis
• In vitro transcription
• In vivo expression

Market Data Breakdown and Growth Pattern by End-Use Industry / Applications

• Drug Discovery and Development
• Therapeutics

Competitive Landscape

In the competitive analysis section of the RNA interference (RNAi) Market Study dominating and emerging players are captured and broadly studied on the basis of key factors such as their product/services offering, differentiation or niche, marketing strategies, geographic footprints, and financial performance. The report offers a comprehensive analysis and accurate statistics on sales for the period 2019-2020. It also offers detailed analysis supported by accurate statistics on price and revenue by player for the period 2019-2020.
Players Profiled in the RNA interference (RNAi) Market Study

• Tekmira Pharmaceuticals Corporation
• Phio Pharmaceuticals Corp.
• Quark Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Dicerna Pharmaceuticals
• Silence Therapeutics PLC
• Qiagen NV
• Arrowhead
• Merck & Co. Inc. (Sigma Aldrich)
• ISIS Pharmaceuticals
• Alnylam Pharmaceuticals
• Thermo Fisher Scientific Inc.
• Benitec Biopharma Ltd
• Arcturus Therapeutics
• RXI Pharmaceuticals

Regional Landscape & Analysis

North America Country (United States, Canada)
South America (Brazil, Argentina, Chile, Rest of South America)
Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Others)
Europe (Germany, United Kingdom, France, Italy, Spain, Switzerland, Netherlands, Sweden, Baltic, rest of Europe)
Rest of World [The United Arab Emirates, Saudi Arabia (KSA), South Africa, Turkey, Israel, Others]


Overall, the RNA interference (RNAi) Market report is a reliable source for managers, analysts, and executives from the industry to better analyze market scenarios from a third-party research perspective. Market Intellix aims to bridge the gap between businesses and end customers to better elaborate manufacturers with benefits, limits, trends, and market growth rates. SWOT analysis is also incorporated in the RNA interference (RNAi) market report in line with speculation attainability investigation and venture return investigation.

Table of Content

1 RNA-interference (RNAi) Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of RNA-interference (RNAi)

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the RNA-interference (RNAi) industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global RNA-interference (RNAi) Market Size, 2015 – 2020

2.1.2 Global RNA-interference (RNAi) Market Size by Type, 2015 – 2020

2.1.3 Global RNA-interference (RNAi) Market Size by Application, 2015 – 2020

2.1.4 Global RNA-interference (RNAi) Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on RNA-interference (RNAi) Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of RNA-interference (RNAi) Analysis

3.2 Major Players of RNA-interference (RNAi)

3.3 RNA-interference (RNAi) Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of RNA-interference (RNAi)

3.3.3 Labor Cost of RNA-interference (RNAi)

3.4 Market Distributors of RNA-interference (RNAi)

3.5 Major Downstream Buyers of RNA-interference (RNAi) Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global RNA-interference (RNAi) Market, by Type

4.1 Global RNA-interference (RNAi) Value and Market Share by Type (2015-2020)

4.2 Global RNA-interference (RNAi) Production and Market Share by Type (2015-2020)

4.3 Global RNA-interference (RNAi) Value and Growth Rate by Type (2015-2020)

4.3.1 Global RNA-interference (RNAi) Value and Growth Rate of Chemical synthesis

4.3.2 Global RNA-interference (RNAi) Value and Growth Rate of In vitro transcription

4.3.3 Global RNA-interference (RNAi) Value and Growth Rate of In vivo expression

4.4 Global RNA-interference (RNAi) Price Analysis by Type (2015-2020)

5 RNA-interference (RNAi) Market, by Application

5.1 Downstream Market Overview

5.2 Global RNA-interference (RNAi) Consumption and Market Share by Application (2015-2020)

5.3 Global RNA-interference (RNAi) Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)

5.3.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)

6 Global RNA-interference (RNAi) Market Analysis by Regions

6.1 Global RNA-interference (RNAi) Sales, Revenue and Market Share by Regions

6.1.1 Global RNA-interference (RNAi) Sales by Regions (2015-2020)

6.1.2 Global RNA-interference (RNAi) Revenue by Regions (2015-2020)

6.2 North America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.3 Europe RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

6.6 South America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7 North America RNA-interference (RNAi) Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

7.2.1 North America RNA-interference (RNAi) Sales by Countries (2015-2020)

7.2.2 North America RNA-interference (RNAi) Revenue by Countries (2015-2020)

7.3 United States RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7.4 Canada RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

7.5 Mexico RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8 Europe RNA-interference (RNAi) Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

8.2.1 Europe RNA-interference (RNAi) Sales by Countries (2015-2020)

8.2.2 Europe RNA-interference (RNAi) Revenue by Countries (2015-2020)

8.3 Germany RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.4 UK RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.5 France RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.6 Italy RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.7 Spain RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

8.8 Russia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9 Asia Pacific RNA-interference (RNAi) Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific RNA-interference (RNAi) Sales by Countries (2015-2020)

9.2.2 Asia Pacific RNA-interference (RNAi) Revenue by Countries (2015-2020)

9.3 China RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.4 Japan RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.5 South Korea RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.6 India RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.7 Southeast Asia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

9.8 Australia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10 Middle East and Africa RNA-interference (RNAi) Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa RNA-interference (RNAi) Sales by Countries (2015-2020)

10.2.2 Middle East and Africa RNA-interference (RNAi) Revenue by Countries (2015-2020)

10.3 Saudi Arabia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.4 UAE RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.5 Egypt RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.6 Nigeria RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

10.7 South Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11 South America RNA-interference (RNAi) Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America RNA-interference (RNAi) Sales, Revenue and Market Share by Countries

11.2.1 South America RNA-interference (RNAi) Sales by Countries (2015-2020)

11.2.2 South America RNA-interference (RNAi) Revenue by Countries (2015-2020)

11.3 Brazil RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11.4 Argentina RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11.5 Columbia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

11.6 Chile RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 Tekmira Pharmaceuticals Corporation

12.1.1 Tekmira Pharmaceuticals Corporation Basic Information

12.1.2 RNA-interference (RNAi) Product Introduction

12.1.3 Tekmira Pharmaceuticals Corporation Production, Value, Price, Gross Margin 2015-2020

12.2 Phio Pharmaceuticals Corp.

12.2.1 Phio Pharmaceuticals Corp. Basic Information

12.2.2 RNA-interference (RNAi) Product Introduction

12.2.3 Phio Pharmaceuticals Corp. Production, Value, Price, Gross Margin 2015-2020

12.3 Quark Pharmaceuticals Inc.

12.3.1 Quark Pharmaceuticals Inc. Basic Information

12.3.2 RNA-interference (RNAi) Product Introduction

12.3.3 Quark Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020

12.4 Ionis Pharmaceuticals Inc.

12.4.1 Ionis Pharmaceuticals Inc. Basic Information

12.4.2 RNA-interference (RNAi) Product Introduction

12.4.3 Ionis Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020

12.5 Dicerna Pharmaceuticals

12.5.1 Dicerna Pharmaceuticals Basic Information

12.5.2 RNA-interference (RNAi) Product Introduction

12.5.3 Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

12.6 Silence Therapeutics PLC

12.6.1 Silence Therapeutics PLC Basic Information

12.6.2 RNA-interference (RNAi) Product Introduction

12.6.3 Silence Therapeutics PLC Production, Value, Price, Gross Margin 2015-2020

12.7 Qiagen NV

12.7.1 Qiagen NV Basic Information

12.7.2 RNA-interference (RNAi) Product Introduction

12.7.3 Qiagen NV Production, Value, Price, Gross Margin 2015-2020

12.8 Arrowhead

12.8.1 Arrowhead Basic Information

12.8.2 RNA-interference (RNAi) Product Introduction

12.8.3 Arrowhead Production, Value, Price, Gross Margin 2015-2020

12.9 Merck & Co. Inc. (Sigma Aldrich)

12.9.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information

12.9.2 RNA-interference (RNAi) Product Introduction

12.9.3 Merck & Co. Inc. (Sigma Aldrich) Production, Value, Price, Gross Margin 2015-2020

12.10 ISIS Pharmaceuticals

12.10.1 ISIS Pharmaceuticals Basic Information

12.10.2 RNA-interference (RNAi) Product Introduction

12.10.3 ISIS Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

12.11 Alnylam Pharmaceuticals

12.11.1 Alnylam Pharmaceuticals Basic Information

12.11.2 RNA-interference (RNAi) Product Introduction

12.11.3 Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

12.12 Thermo Fisher Scientific Inc.

12.12.1 Thermo Fisher Scientific Inc. Basic Information

12.12.2 RNA-interference (RNAi) Product Introduction

12.12.3 Thermo Fisher Scientific Inc. Production, Value, Price, Gross Margin 2015-2020

12.13 Benitec Biopharma Ltd

12.13.1 Benitec Biopharma Ltd Basic Information

12.13.2 RNA-interference (RNAi) Product Introduction

12.13.3 Benitec Biopharma Ltd Production, Value, Price, Gross Margin 2015-2020

12.14 Arcturus Therapeutics

12.14.1 Arcturus Therapeutics Basic Information

12.14.2 RNA-interference (RNAi) Product Introduction

12.14.3 Arcturus Therapeutics Production, Value, Price, Gross Margin 2015-2020

12.15 RXI Pharmaceuticals

12.15.1 RXI Pharmaceuticals Basic Information

12.15.2 RNA-interference (RNAi) Product Introduction

12.15.3 RXI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global RNA-interference (RNAi) Market Forecast

14.1 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Chemical synthesis Market Value and Volume Forecast (2020-2025)

14.1.2 In vitro transcription Market Value and Volume Forecast (2020-2025)

14.1.3 In vivo expression Market Value and Volume Forecast (2020-2025)

14.2 Global RNA-interference (RNAi) Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Drug Discovery and Development Market Value and Volume Forecast (2020-2025)

14.2.2 Therapeutics Market Value and Volume Forecast (2020-2025)

14.3 RNA-interference (RNAi) Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

 

List of Tables and Figures

Figure Product Picture of RNA-interference (RNAi)

Table Product Specification of RNA-interference (RNAi)

Table RNA-interference (RNAi) Key Market Segments

Table Key Players RNA-interference (RNAi) Covered

Figure Global RNA-interference (RNAi) Market Size, 2015 – 2025

Table Different Types of RNA-interference (RNAi)

Figure Global RNA-interference (RNAi) Value ($) Segment by Type from 2015-2020

Figure Global RNA-interference (RNAi) Market Share by Types in 2019

Table Different Applications of RNA-interference (RNAi)

Figure Global RNA-interference (RNAi) Value ($) Segment by Applications from 2015-2020

Figure Global RNA-interference (RNAi) Market Share by Applications in 2019

Figure Global RNA-interference (RNAi) Market Share by Regions in 2019

Figure North America RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure Europe RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure Asia Pacific RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure Middle East and Africa RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Figure South America RNA-interference (RNAi) Production Value ($) and Growth Rate (2015-2020)

Table Global COVID-19 Status and Economic Overview

Figure Global COVID-19 Status

Figure COVID-19 Comparison of Major Countries

Figure Industry Chain Analysis of RNA-interference (RNAi)

Table Upstream Raw Material Suppliers of RNA-interference (RNAi) with Contact Information

Table Major Players Headquarters, and Service Area of RNA-interference (RNAi)

Figure Major Players Production Value Market Share of RNA-interference (RNAi) in 2019

Table Major Players RNA-interference (RNAi) Product Types in 2019

Figure Production Process of RNA-interference (RNAi)

Figure Manufacturing Cost Structure of RNA-interference (RNAi)

Figure Channel Status of RNA-interference (RNAi)

Table Major Distributors of RNA-interference (RNAi) with Contact Information

Table Major Downstream Buyers of RNA-interference (RNAi) with Contact Information

Table Global RNA-interference (RNAi) Value ($) by Type (2015-2020)

Table Global RNA-interference (RNAi) Value Share by Type (2015-2020)

Figure Global RNA-interference (RNAi) Value Share by Type (2015-2020)

Table Global RNA-interference (RNAi) Production by Type (2015-2020)

Table Global RNA-interference (RNAi) Production Share by Type (2015-2020)

Figure Global RNA-interference (RNAi) Production Share by Type (2015-2020)

Figure Global RNA-interference (RNAi) Value ($) and Growth Rate of Chemical synthesis (2015-2020)

Figure Global RNA-interference (RNAi) Value ($) and Growth Rate of In vitro transcription (2015-2020)

Figure Global RNA-interference (RNAi) Value ($) and Growth Rate of In vivo expression (2015-2020)

Figure Global RNA-interference (RNAi) Price by Type (2015-2020)

Figure Downstream Market Overview

Table Global RNA-interference (RNAi) Consumption by Application (2015-2020)

Table Global RNA-interference (RNAi) Consumption Market Share by Application (2015-2020)

Figure Global RNA-interference (RNAi) Consumption Market Share by Application (2015-2020)

Figure Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)

Figure Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)

Figure Global RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Global RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Global RNA-interference (RNAi) Sales by Regions (2015-2020)

Table Global RNA-interference (RNAi) Sales Market Share by Regions (2015-2020)

Table Global RNA-interference (RNAi) Revenue (M USD) by Regions (2015-2020)

Table Global RNA-interference (RNAi) Revenue Market Share by Regions (2015-2020)

Table Global RNA-interference (RNAi) Revenue Market Share by Regions in 2015

Table Global RNA-interference (RNAi) Revenue Market Share by Regions in 2019

Figure North America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Europe RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Asia-Pacific RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Middle East and Africa RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure South America RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure North America COVID-19 Confirmed Cases Major Distribution

Figure North America RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table North America RNA-interference (RNAi) Sales by Countries (2015-2020)

Table North America RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table North America RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table North America RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure United States RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Canada RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Mexico RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Europe COVID-19 Status

Figure Europe COVID-19 Confirmed Cases Major Distribution

Figure Europe RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Europe RNA-interference (RNAi) Sales by Countries (2015-2020)

Table Europe RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table Europe RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table Europe RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure Germany RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure UK RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure France RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Italy RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Spain RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Russia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Asia Pacific RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Sales by Countries (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table Asia Pacific RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure China RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Japan RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure South Korea RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure India RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Southeast Asia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Australia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Middle East RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table Middle East RNA-interference (RNAi) Sales by Countries (2015-2020)

Table Middle East and Africa RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table Middle East and Africa RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table Middle East and Africa RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure Saudi Arabia RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure UAE RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Egypt RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Nigeria RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure South Africa RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure South America RNA-interference (RNAi) Revenue (M USD) and Growth (2015-2020)

Table South America RNA-interference (RNAi) Sales by Countries (2015-2020)

Table South America RNA-interference (RNAi) Sales Market Share by Countries (2015-2020)

Table South America RNA-interference (RNAi) Revenue (M USD) by Countries (2015-2020)

Table South America RNA-interference (RNAi) Revenue Market Share by Countries (2015-2020)

Figure Brazil RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Argentina RNA-interference (RNAi) Sales and Growth Rate (2015-2020)

Figure Columbia RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Chile RNA-interference (RNAi) Sales and Growth (2015-2020)

Figure Top 3 Market Share of RNA-interference (RNAi) Companies in 2019

Figure Top 6 Market Share of RNA-interference (RNAi) Companies in 2019

Table Major Players Production Value ($) Share (2015-2020)

Table Tekmira Pharmaceuticals Corporation Profile

Table Tekmira Pharmaceuticals Corporation Product Introduction

Figure Tekmira Pharmaceuticals Corporation Production and Growth Rate

Figure Tekmira Pharmaceuticals Corporation Value ($) Market Share 2015-2020

Table Phio Pharmaceuticals Corp. Profile

Table Phio Pharmaceuticals Corp. Product Introduction

Figure Phio Pharmaceuticals Corp. Production and Growth Rate

Figure Phio Pharmaceuticals Corp. Value ($) Market Share 2015-2020

Table Quark Pharmaceuticals Inc. Profile

Table Quark Pharmaceuticals Inc. Product Introduction

Figure Quark Pharmaceuticals Inc. Production and Growth Rate

Figure Quark Pharmaceuticals Inc. Value ($) Market Share 2015-2020

Table Ionis Pharmaceuticals Inc. Profile

Table Ionis Pharmaceuticals Inc. Product Introduction

Figure Ionis Pharmaceuticals Inc. Production and Growth Rate

Figure Ionis Pharmaceuticals Inc. Value ($) Market Share 2015-2020

Table Dicerna Pharmaceuticals Profile

Table Dicerna Pharmaceuticals Product Introduction

Figure Dicerna Pharmaceuticals Production and Growth Rate

Figure Dicerna Pharmaceuticals Value ($) Market Share 2015-2020

Table Silence Therapeutics PLC Profile

Table Silence Therapeutics PLC Product Introduction

Figure Silence Therapeutics PLC Production and Growth Rate

Figure Silence Therapeutics PLC Value ($) Market Share 2015-2020

Table Qiagen NV Profile

Table Qiagen NV Product Introduction

Figure Qiagen NV Production and Growth Rate

Figure Qiagen NV Value ($) Market Share 2015-2020

Table Arrowhead Profile

Table Arrowhead Product Introduction

Figure Arrowhead Production and Growth Rate

Figure Arrowhead Value ($) Market Share 2015-2020

Table Merck & Co. Inc. (Sigma Aldrich) Profile

Table Merck & Co. Inc. (Sigma Aldrich) Product Introduction

Figure Merck & Co. Inc. (Sigma Aldrich) Production and Growth Rate

Figure Merck & Co. Inc. (Sigma Aldrich) Value ($) Market Share 2015-2020

Table ISIS Pharmaceuticals Profile

Table ISIS Pharmaceuticals Product Introduction

Figure ISIS Pharmaceuticals Production and Growth Rate

Figure ISIS Pharmaceuticals Value ($) Market Share 2015-2020

Table Alnylam Pharmaceuticals Profile

Table Alnylam Pharmaceuticals Product Introduction

Figure Alnylam Pharmaceuticals Production and Growth Rate

Figure Alnylam Pharmaceuticals Value ($) Market Share 2015-2020

Table Thermo Fisher Scientific Inc. Profile

Table Thermo Fisher Scientific Inc. Product Introduction

Figure Thermo Fisher Scientific Inc. Production and Growth Rate

Figure Thermo Fisher Scientific Inc. Value ($) Market Share 2015-2020

Table Benitec Biopharma Ltd Profile

Table Benitec Biopharma Ltd Product Introduction

Figure Benitec Biopharma Ltd Production and Growth Rate

Figure Benitec Biopharma Ltd Value ($) Market Share 2015-2020

Table Arcturus Therapeutics Profile

Table Arcturus Therapeutics Product Introduction

Figure Arcturus Therapeutics Production and Growth Rate

Figure Arcturus Therapeutics Value ($) Market Share 2015-2020

Table RXI Pharmaceuticals Profile

Table RXI Pharmaceuticals Product Introduction

Figure RXI Pharmaceuticals Production and Growth Rate

Figure RXI Pharmaceuticals Value ($) Market Share 2015-2020

Table Market Driving Factors of RNA-interference (RNAi)

Table Merger, Acquisition and New Investment

Table Global RNA-interference (RNAi) Market Value ($) Forecast, by Type

Table Global RNA-interference (RNAi) Market Volume Forecast, by Type

Figure Global RNA-interference (RNAi) Market Value ($) and Growth Rate Forecast of Chemical synthesis (2020-2025)

Figure Global RNA-interference (RNAi) Market Volume ($) and Growth Rate Forecast of Chemical synthesis (2020-2025)

Figure Global RNA-interference (RNAi) Market Value ($) and Growth Rate Forecast of In vitro transcription (2020-2025)

Figure Global RNA-interference (RNAi) Market Volume ($) and Growth Rate Forecast of In vitro transcription (2020-2025)

Figure Global RNA-interference (RNAi) Market Value ($) and Growth Rate Forecast of In vivo expression (2020-2025)

Figure Global RNA-interference (RNAi) Market Volume ($) and Growth Rate Forecast of In vivo expression (2020-2025)

Table Global Market Value ($) Forecast by Application (2020-2025)

Table Global Market Volume Forecast by Application (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Drug Discovery and Development (2020-2025)

Figure Market Volume and Growth Rate Forecast of Drug Discovery and Development (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Therapeutics (2020-2025)

Figure Market Volume and Growth Rate Forecast of Therapeutics (2020-2025)

Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure North America Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Europe Consumption and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure South America Consumption and Growth Rate Forecast (2020-2025)

Figure Porter’s Five Forces Analysis

Table New Entrants SWOT Analysis

Table New Project Analysis of Investment Recovery

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)